MCT is proud to be successfully running a Polio Vaccine study with 1,119 patients randomized within 5 months and targeting around 3,000 patients by March 2022.
Related Posts
Marwan Felaefel speaker at PRIM&R – AER conference in Boston on Nov 12-Nov15
News / November 18, 2015